PI
AMED

PineBridge Investments’s Amedisys AMED Stock Holding History

PineBridge Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,118
Closed -$1.37M – 718
2024
Q4 		$1.37M Buy
15,118
+4,374
+41% +$402K 0.01% 617
2024
Q3 		$1.04M Buy
+10,744
New +$1.05M 0.01% 648
2023
Q3 		– Sell
-287
Closed -$26.2K – 693
2023
Q2 		$26.2K Buy
+287
New +$23.5K ﹤0.01% 773
2019
Q1 		– Sell
-6,704
Closed -$785K – 1074
2018
Q4 		$785K Buy
6,704
+854
+15% +$101K 0.02% 573
2018
Q3 		$731K Buy
5,850
+1,081
+23% +$119K 0.01% 677
2018
Q2 		$408K Sell
4,769
-385
-7% -$28.3K 0.01% 727
2018
Q1 		$311K Sell
5,154
-41,521
-89% -$2.37M 0.01% 789
2017
Q4 		$2.46M Buy
46,675
+15,162
+48% +$799K 0.06% 285
2017
Q3 		$1.76M Buy
31,513
+12
+0% +$635 0.04% 334
2017
Q2 		$1.98M Buy
31,501
+10,896
+53% +$635K 0.05% 279
2017
Q1 		$1.05M Buy
20,605
+6,128
+42% +$292K 0.03% 482
2016
Q4 		$617K Buy
14,477
+10,937
+309% +$465K 0.02% 573
2016
Q3 		$168K Sell
3,540
-20
-0.6% -$998 0.01% 569
2016
Q2 		$180K Buy
3,560
+101
+3% +$5.1K 0.01% 531
2016
Q1 		$167K Sell
3,459
-340
-9% -$13.1K 0.01% 545
2015
Q4 		$149K Sell
3,799
-498
-12% -$19.9K 0.01% 617
2015
Q3 		$164K Buy
4,297
+404
+10% +$17K 0.01% 587
2015
Q2 		$154K Sell
3,893
-4,830
-55% -$150K 0.01% 595
2015
Q1 		$233K Buy
8,723
+1,245
+17% +$35.1K 0.01% 690
2014
Q4 		$220K Buy
7,478
+322
+4% +$7.95K 0.01% 685
2014
Q3 		$144K Buy
7,156
+2,220
+45% +$42.8K 0.01% 754
2014
Q2 		$83K Sell
4,936
-2,965
-38% -$42K ﹤0.01% 846
2014
Q1 		$118K Sell
7,901
-792
-9% -$12.2K ﹤0.01% 909
2013
Q4 		$128K Buy
8,693
+4,983
+134% +$80.2K ﹤0.01% 917
2013
Q3 		$64K Buy
3,710
+471
+15% +$6.99K ﹤0.01% 863
2013
Q2 		$37K Buy
+3,239
New +$37.1K ﹤0.01% 986

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

PineBridge Investments's AMED Position: Q1 2025 in Review

PineBridge Investments sold out of Amedisys (AMED) in Q1 2025, closing a stake of 15,118 shares — an estimated $1.37M sold.

PineBridge Investments first reported a position in AMED in Q2 2013 and held it in 26 quarters. The position peaked at $2.46M in Q4 2017. 304 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • PineBridge Investments reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • PineBridge Investments sold 15,118 Amedisys shares in Q1 2025, an estimated $1.37M.
  • PineBridge Investments first reported a position in Amedisys in Q2 2013 and held it in 26 quarters.
  • PineBridge Investments's Amedisys position peaked at $2.46M in Q4 2017.
  • 304 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on PineBridge Investments's 13F filing for Q1 2025, filed 14 May 2025.